[1]
2025. Assessment of Prognostic Value of Delayed-Type Hypersensitivity (DTH) Reaction in The Application of Autologous Dendritic Cell Vaccine in Patients with Melanoma and Soft Tissue Sarcomas. Voprosy onkologii. 70, 6 (Jan. 2025), 1077–1085. DOI:https://doi.org/10.37469/0507-3758-2024-70-6-1077-1085.